Main Sequence is a venture capital firm that focuses on investing in deep technology companies translating Australian research into global businesses, aiming to solve major global challenges like decarbonization and feeding a growing population. Their strategy involves early-stage investments (seed to Series B) and a "venture science" model, actively partnering with researchers and universities to build companies from scientific discoveries.
Portfolio
11
Fund Size
$1B
Top Stage
Series B
Last 12 Mo
2
Stage Distribution
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Uluu | Series A | $16M | Oct 2025 |
| Morse Micro | Series C | $59M | Sep 2025 |
| JDoodle | Seed | $2.2M | Jun 2023 |
| Endua | Series A | $7.8M | May 2023 |
| Uluu | Seed | $5.3M | Nov 2022 |
| Lumachain | Series A | $19.5M | Aug 2022 |
| Q-CTRL | Series B | $25M | Nov 2021 |
| v2Food | Series B | $45M | Aug 2021 |
| Baraja | Series B | $31M | Mar 2021 |
| Emesent | Seed | $2.5M | Nov 2018 |
| Gilmour Space | Series B | $36M | — |
Top Co-Investors
Blackbird3 shared
Hostplus2 shared
Airbus Ventures1 shared
Horizon Ventures1 shared
Square Peg Capital1 shared
Sierra Ventures1 shared
DCVC1 shared
Sequoia China1 shared
In-Q-Tel1 shared
Burda Principal Investments1 shared
Startmate1 shared
Trinity Ventures1 shared
Bessemer Venture Partners1 shared
Queensland Investment Corporation1 shared
Astanor1 shared
HESTA1 shared
Regal1 shared
Last updated: 3 March 2026